Games, Magnets, and Paper Forms: Your Brain Today

Story-Based Games Gave Preschoolers Meaningfully Better Self-Control

What if 18 months of story-based games gave a four-year-old measurably better control over their own impulses?

A team publishing in Frontiers in Psychology ran a three-arm experiment with 180 preschoolers, aged four to five-and-a-half, over 18 months. One group played interactive literary narrative games — story-driven activities where children made choices, acted out scenes, and followed narrative arcs. A second group did traditional storytelling and reading circles. The third followed a standard curriculum. The results were large. At the 18-month mark, children in the game group showed substantial improvements in what psychologists call executive function — essentially, your brain's internal manager. Think of it like a traffic controller stationed inside your head: it decides when to stop, when to switch lanes, and how much to hold in memory at once. At age four, that controller is barely trained. Working memory — holding information while you use it, like remembering three instructions at once — improved with an effect size of d=0.85. Inhibitory control — stopping yourself from grabbing something impulsive — improved at d=0.73. Cognitive flexibility — switching tasks without melting down — came in at d=0.81. EEG recordings backed up the behavioral scores, showing patterns the authors interpret as more efficient neural processing in the game group. The catch: the study doesn't mention pre-registration, and there's no description of whether assessors were blinded to which group each child was in. Those are meaningful gaps. Effect sizes this large in a study of 180 children sometimes shrink significantly when replicated at larger scale. This is the kind of finding that should prompt bigger trials — not the kind that should change school policy yet. A small but real step.

Magnetic Brain Stimulation Shows Promise Against Alzheimer's — With Real Caveats

A magnetic coil held near your scalp can make brain cells fire differently — and for millions of people with Alzheimer's, that detail might eventually matter.

Hold a strong magnet near a copper wire and you generate an electric current without touching the wire. Transcranial magnetic stimulation, or TMS, does something analogous with neurons: a coil held outside your skull produces a brief magnetic field that nudges brain cells into activity — or quiets them down — without surgery, needles, or drugs. Repetitive TMS (rTMS) delivers this in rhythmic pulses, like tapping a slow beat on the outside of the skull to wake up sluggish circuits inside. A team publishing in Frontiers in Aging Neuroscience reviewed five years of clinical trials, observational studies, and experimental work on rTMS across the spectrum from healthy older adults to people with mild cognitive impairment — a state of noticeable memory decline that often precedes dementia — through to full Alzheimer's disease. Their bottom line: rTMS is classified as 'possibly effective' for improving cognitive outcomes in MCI and Alzheimer's. That classification comes from Lefaucheur et al. 2020 clinical guidelines. 'Level C evidence' is medical shorthand for 'we see real signals, but the evidence isn't airtight.' Given that roughly 10% of Americans over 65 have dementia and about 22% have MCI, a non-drug, low-side-effect therapy with no reported drug interactions is worth watching carefully. The catch is substantial: this is a narrative review. The authors read and summarized other people's studies — they ran no new experiments and pooled no numbers. They report zero original effect sizes. 'Possibly effective' also sits near the bottom of the clinical evidence ladder. We are watching a plausible therapy accumulate support. We are not celebrating a proven treatment.

Only 6% of Brain Tests Are Digital — Here's Why That's Stuck

Only 6 in every 100 neuropsychological tests given by a clinician are done on a computer — in 2025.

When a psychologist needs to measure your memory, attention, or cognitive health — to catch early dementia, evaluate a brain injury, or assess ADHD — they often hand you a paper booklet. A pencil, some blocks, a timed task. The digital version of these tests has existed for decades. So why hasn't it taken over? A team publishing in the Journal of Medical Systems searched eight major databases covering work from 1998 to 2025 and included 48 empirical studies. Their scoping review — a type of research that maps what's known without pooling statistics — found that only 6% of instruments currently used by neuropsychologists are computerized. Think of it like a law firm that still mails paper contracts instead of using e-signatures — not because the technology is missing, but because the habits, the trust, and the infrastructure haven't caught up. The researchers mapped the obstacles and enablers across 13 behavioral and organizational categories. The blockers are predictable: patients anxious around devices, poor connectivity in rural areas, physical limitations that make touchscreens difficult, and clinicians who worry they'll miss subtle behavioral cues they'd catch in person. The enablers are equally clear: thorough training, reliable hardware, and actually building systems around what patients and clinicians say they need — rather than assuming they'll adapt. The catch — and it's an honest one — is that a scoping review diagnoses. It doesn't treat. This paper tells you precisely why digital brain testing is stuck. It does not test any solution. The distance between naming a problem and solving it is where most implementation stories quietly die.

These three papers, read together, point at the same tension: we know more than we act on. We have evidence that structured activities — even story games — can shape a developing brain over 18 months. We have signals that a non-drug tool like rTMS can nudge the aging brain toward better function. And we have a field that, after 25 years of digital alternatives, still defaults to pencil and paper for its most fundamental assessments. None of today's papers announces a fix. But each one presses on the same underlying question: what does it actually take to move a good idea from a lab into a person's life? The gamification study answers: 18 months of consistent, engaging exposure. The TMS review answers: more and better-designed trials. The technology review answers: training, trust, and decent Wi-Fi. Honest answers, all of them. The fact that such different problems keep running into the same wall is worth sitting with.

Two things to track. First, whether the preschool gamification findings survive a larger, pre-registered replication — effect sizes this striking almost always attract follow-up attempts, and the result could go either way. Second, TMS for Alzheimer's is edging toward stronger clinical guidelines; the Alzheimer's Association International Conference later this year could surface new multi-site trial data that moves rTMS's evidence rating up a notch — or forces a rethink.

• Wikipedia: Executive Functions — background on the cognitive skills tested in the preschool study
• Wikipedia: Transcranial Magnetic Stimulation — how the technique works, in plain terms
• Wikipedia: Neuropsychological Assessment — what these tests actually involve